Barclays Maintains Underweight on Molina Healthcare, Raises Price Target to $161
Morgan Stanley Maintains Equal-Weight on Molina Healthcare, Raises Price Target to $146
Molina: Q1 Beat Proves The Cost Story, Now Comes Hard Decision For The Management
Molina Healthcare (NYSE:MOH) Navigates Membership Decline, Reaffirms 2026 Outlook
Loading...